LCTX
Lineage Cell Therapeutics Inc
NYSE MKT: LCTX · HEALTHCARE · BIOTECHNOLOGY
$1.43
-2.05% today
Updated 2026-05-06
Market cap
$363.98M
P/E ratio
—
P/S ratio
25.01x
EPS (TTM)
$-0.28
Dividend yield
—
52W range
$0 – $2
Volume
1.2M
Lineage Cell Therapeutics Inc (LCTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.16M | $1.05M | $1.50M | $1.93M | $3.68M | $4.35M | $1.69M | $2.86M | $1.95M | $2.53M | $2.25M | $1.79M | $1.42M | $1.48M | $773000.00 | $3.90M | $14.70M | $8.95M | $9.50M | $14.56M |
| Revenue growth (YoY) | — | -10.0% | +43.7% | +28.0% | +91.2% | +18.3% | -61.1% | +69.0% | -32.0% | +30.2% | -11.1% | -20.4% | -21.0% | +4.4% | -47.7% | +404.0% | +277.4% | -39.2% | +6.2% | +53.2% |
| Cost of revenue | — | — | — | — | — | — | $434271.00 | $792659.00 | $837052.00 | $1.11M | $358000.00 | $168000.00 | $302000.00 | $412000.00 | $385000.00 | $1.43M | $728000.00 | $671000.00 | $334000.00 | $845000.00 |
| Gross profit | $1.16M | $1.05M | $1.50M | $1.93M | $3.68M | $4.35M | $1.26M | $2.07M | $1.11M | $1.43M | $1.89M | $1.62M | $1.11M | $1.07M | $388000.00 | $2.47M | $13.97M | $8.27M | $9.16M | $13.71M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 74.3% | 72.3% | 57.0% | 56.3% | 84.1% | 90.6% | 78.7% | 72.1% | 50.2% | 63.4% | 95.0% | 92.5% | 96.5% | 94.2% |
| R&D | $1.42M | $967864.00 | $1.71M | $2.97M | $7.89M | $13.70M | $18.12M | $26.61M | $37.53M | $42.60M | $36.11M | $24.02M | $20.95M | $17.95M | $12.32M | $33.91M | $13.99M | $15.71M | $12.47M | $17.73M |
| SG&A | $1.49M | $1.30M | $2.62M | $2.48M | $5.64M | $9.34M | $10.37M | $15.56M | $17.56M | $29.13M | $28.43M | $19.92M | $24.73M | $24.03M | $15.57M | $18.21M | $22.51M | $17.30M | $18.17M | $18.46M |
| Operating income | $-1.75M | $-1.22M | $-2.82M | $-3.52M | $-9.85M | $-18.69M | $-25.00M | $-55.99M | $-50.68M | $-65.81M | $-58.97M | $-38.90M | $-41.80M | $-38.88M | $-26.45M | $-49.21M | $-22.52M | $-24.73M | $-21.48M | $-21.78M |
| Operating margin | -150.8% | -116.8% | -187.7% | -182.9% | -267.7% | -429.1% | -1476.8% | -1956.8% | -2604.0% | -2597.0% | -2618.4% | -2170.9% | -2951.6% | -2630.3% | -3421.3% | -1263.1% | -153.2% | -276.5% | -226.1% | -149.6% |
| EBITDA | $-1.75M | $-1.24M | $-2.80M | $-3.49M | $-8.92M | $-16.32M | $-22.17M | $-34.57M | $-42.27M | $-59.48M | $-54.21M | $-37.36M | $-37.72M | $-35.88M | $-24.41M | $-48.34M | $-21.79M | $-24.04M | $-20.87M | $-21.08M |
| EBITDA margin | -150.8% | -118.5% | -186.1% | -181.1% | -242.5% | -374.8% | -1309.4% | -1208.5% | -2171.8% | -2347.1% | -2407.2% | -2084.8% | -2664.0% | -2427.3% | -3157.6% | -1240.7% | -148.2% | -268.8% | -219.7% | -144.8% |
| EBIT | $-1.78M | $-1.05M | $-2.82M | $-3.52M | $-9.85M | $-18.69M | $-25.00M | $-38.53M | $-50.68M | $-65.81M | $-58.97M | $-40.66M | $-40.99M | $-38.88M | $-26.45M | $-49.21M | $-22.52M | $-24.73M | $-21.48M | $-21.78M |
| Interest expense | $157114.00 | $16926.00 | $965781.00 | $1.65M | $124300.00 | $212821.00 | $305183.00 | $26.09M | $91047.00 | $340000.00 | $747000.00 | $692000.00 | $10.87M | $1.69M | $5.16M | $2000.00 | $5.18M | — | — | — |
| Income tax | $-88714.00 | $388157.00 | $-15036.00 | $-60224.00 | $3.42M | $-2.38M | $-3.57M | $-3.28M | $-7.38M | $-4.52M | $-175.95M | $-37.29M | $-346000.00 | $-7.41M | $-1.24M | $-4.71M | $541000.00 | $-1.80M | $27000.00 | — |
| Effective tax rate | 4.5% | -37.0% | 0.4% | 1.2% | -44.0% | 12.6% | 14.3% | 7.0% | 16.8% | 8.8% | 123.6% | 65.1% | 0.7% | 38.7% | 5.7% | 9.9% | -2.1% | 7.7% | -0.1% | 0.0% |
| Net income | $-1.86M | $-1.44M | $-3.78M | $-5.14M | $-11.18M | $-16.52M | $-21.43M | $-43.88M | $-36.41M | $-46.99M | $33.57M | $-19.98M | $-45.99M | $-11.71M | $-20.65M | $-43.02M | $-26.27M | $-21.49M | $-18.61M | $-63.53M |
| Net income growth (YoY) | — | +22.9% | -162.9% | -36.1% | -117.4% | -47.7% | -29.7% | -104.8% | +17.0% | -29.1% | +171.4% | -159.5% | -130.2% | +74.5% | -76.4% | -108.3% | +38.9% | +18.2% | +13.4% | -241.4% |
| Profit margin | -160.5% | -137.5% | -251.4% | -267.2% | -303.9% | -379.3% | -1265.6% | -1533.8% | -1870.7% | -1854.4% | 1490.8% | -1114.7% | -3247.9% | -792.2% | -2671.3% | -1104.2% | -178.7% | -240.2% | -195.9% | -436.5% |